Tourmaline Bio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $40 | $0 | $0 | $0 |
Gross Profit | 20 | -10 | -10 | |
EBITDA | -25,797 | -24,428 | -21,971 | -17,507 |
EBIT | -25,806 | -24,438 | -21,981 | -17,517 |
Net Income | -22,235 | -20,177 | -17,487 | -13,311 |
Net Change In Cash | 40 | 0 | 0 | 0 |
Free Cash Flow | -20,898 | -23,444 | -18,007 | -14,923 |
Cash | 30,506 | 35,008 | 70,148 | 98,286 |
Basic Shares | 25,796 | 25,767 | 25,724 | 24,082 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -33 | -6 | |
EBITDA | -89,732 | -45,376 | -19,695 |
EBIT | -45,409 | -19,701 | |
Net Income | -73,210 | -42,124 | -19,701 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -77,272 | -28,137 | -11,526 |
Cash | 30,506 | 140,726 | 8,258 |
Basic Shares | 25,348 | 4,747 | 20,336 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.86 |
2024-09-30 | -$0.78 |
2024-06-30 | -$0.68 |
2024-03-31 | -$0.55 |
